AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Soiken Holdings Inc.
  3. Financials
  4. EBITDA margin (%)

Soiken Holdings Inc.【JP:2385】

Market cap
¥6.3B
P/E ratio
210.4x
Soken Medical Holdings develops biomarker testing systems for food and pharmaceutical companies while selling health products directly to consumers.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Jun 30, 2025-2.5-78.28%
Jun 30, 2024-11.3-221.72%
Jun 30, 20239.3-29.33%
Jun 30, 202213.1+24.49%
Jun 30, 202110.6-8.87%
Jun 30, 202011.6-2.29%
Jun 30, 201911.9+83.13%
Jun 30, 20186.5-5.88%
Jun 30, 20176.9+11.50%
Jun 30, 20166.2+2312.69%
Jun 30, 20150.3-86.96%
Jun 30, 20142

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)